At first glance, electric vehicle (EV) battery technology company QuantumScape (NYSE:QS) might sound like a great business to invest in. After all, QS stock moved higher in November and early December. Yet, caution is definitely advised as QuantumScape’s financial shortcomings can’t be ignored. Besides, as we’ll explain today, a prominent analyst firm published a low price
0 Comments
There’s no doubt about it. It’s been a great year to invest in Nvidia (NASDAQ:NVDA), the most magnificent of the “Magnificent Seven” companies. However, Nvidia isn’t the only artificial intelligence (AI) processor arms race competitor. Indeed, a comeback contender in the AI chip industry should make eager NVDA stock buyers think twice.           
0 Comments
It’s clear to anyone who follows the market which stocks outperformed in 2023. Artificial intelligence and weight loss drug companies led the way. But what about the year ahead? Which securities will ascend to new heights in 2024 and pull the market up with them? Analysts and market commentators are busy with their predictions and
0 Comments
SmileDirectClub (OTCMKTS:SDCCQ) ceased operating on December 8 after it could not restructure through bankruptcy proceedings. The once high-flying provider of dental aligners was one of many at-risk companies entering the final quarter of 2023.  Do you remember all the articles pitting SmileDirect against industry leader Align Technology (NASDAQ:ALGN)? I sure do.  As recently as 2020,
0 Comments
As we usher in a a burgeoning bull market in 2024, it’s paramount to turn our attention to the top cloud computing stocks. The last decade has showcased cloud computing’s role in revolutionizing business operations, enhancing collaboration, scalability, cost-effectiveness, and data security. With these benefits, the cloud computing market is gearing up for massive growth,
0 Comments
Since the end of October, stocks have rallied tremendously, with the S&P 500 soaring 15% and the Russell 2000 jumping 21%. This huge rebound, brought about by greater confidence in the economy and less trepidation about interest rates, resulted in many drastically overvalued stocks. For long-term, risk-tolerant investors, the latter situation created a good opportunity.
0 Comments
Genomics is undeniably medicine’s future, and genomics stocks stand to be the next big thing in healthcare as the industry matures. But the crux of the matter is when the industry will mature. Medical advancement lead times, regulatory approval, and expensive R&D combine to make genomics stocks a risky speculative play today while we await
0 Comments
Investor Cathie Wood deserves to take a victory lap. After being vilified for almost two years for allocating capital to disruptive technology stocks, Wood’s 2023 strategy has proven successful. The flagship ARK Innovation (NYSEARCA:ARKK) exchange-traded fund (ETF) that Wood runs through her investment management firm Ark Invest is up 70% this year. After enduring the
0 Comments
While the topic of top penny stocks to buy may arouse controversy similar to apocryphal literature with spiritual implications. That might sound hyperbolic but generally, financial advisors shy away from the sector because of the extreme risks involved. It’s not just that investing in this arena is dangerous to your financial standing; rather, the ecosystem
0 Comments
 Growth stocks certainly have legs at the moment and it’s fair to assume that there will be a surge of investment heading into 2024. Demand should be expected to rise as the Federal Reserve continues to signal that the worst is over. The markets are expecting a soft landing and multiple rate cuts in 2024.
0 Comments
Well, 2023 certainly hasn’t been perfect for stocks, but with volatility and uncertainty lingering after the chaos of 2022, it’s been better than expected for most investors. Many people braced themselves for a downturn this year amid Fed rate hikes, but the market has shown impressive resilience and even a nice recovery. As we round
0 Comments